Exploiting intracellular iron and iron-rich compounds to effect tumor cell lysis

Medical Hypotheses

Volumn 61, Issue 2, 2003, Pages 206-209

  Payne, Anthony G ^a  

^a Stem Cell Therapies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ARTEMISININ; ARTEMISININ DERIVATIVE; DEFEROXAMINE; DIHYDROARTEMISININ; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FERROUS CITRATE; FERROUS GLUCONATE; FERROUS SULFATE; GLUCOSE; HOLOTRANSFERRIN; IRON; IRON DERIVATIVE; LEVODOPA; MANGANESE; PHTHALOCYANINE DERIVATIVE; QUERCETIN DERIVATIVE; SESQUITERPENE LACTONE; TANNIN DERIVATIVE; TETRACYCLINE; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG; ZINC;

BIOACCUMULATION; CANCER INHIBITION; CANCER RADIOTHERAPY; CELLULAR DISTRIBUTION; CYTOLYSIS; DRUG INDICATION; HUMAN; HYPERTHERMIC THERAPY; LYMPHOSARCOMA; MASTOCYTOMA; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR CELL;

EID: 0041621558     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(03)00110-5     Document Type: Article

References (24)

1. Weinberg E. D. Roles of iron in neoplasia. Promotion, prevention, and therapy. Biol Trace Elem Res 1992; 34(2): 123-140.
2. Fujiwara K., Watanabe T. Effects of hyperthermia, radiotherapy and thermoradiotherapy on tumor microvascular permeability. Acta Pathol Jpn 1990; 40(2): 79-184.
3. Cook J. D., Reddy M. B. Effect of ascorbic acid intake on nonheme-iron absorption from a complete diet. Am J Clin Nutr 2001; 73(1): 93-98.
4. Hallberg L., Brune M., Rossander-Hulthen L. 'Is there a physiological role of vitamin C in iron absorption. Ann NY Acad Sci 1987; 498: 324-332.
5. Moutafchiev D. A., Sirakov L. M. Effect of insulin and adrenaline on the 59Fe transferinn uptake of lactating mouse mammary gland cells. Horm Metab Res 1992; 24(9): 420-423.
6. Davis R. J., Corvera S., Czech M. P. Insulin stimulates cellular iron uptake and causes the redistribution of intracellular transferrin receptors to the plasma membrane. J Biol Chem 1986; 261(19): 8708-8711.
7. Insulin Potentiation Therapy Bibliography: http://www.iptq.com/bibliogr.htm.
8. Pontigi P., Rotella G. B., Sabuto A., Curto F. C. Hyperthermia in cancer and AIDS: an updated survey. J Environ Toxicol Oncol 1996; 15(2-4): 89-97.
9. Babincova M., Leszczynska D., Sourivong P., Babinec P. Selective treatment of neoplastic cells using ferritin-mediated electromagnetic hyperthermia. Med Hypotheses 2000; 54(2): 177-179.
10. Mitsumori M., Hiraoka M., Shibata T., Okuno Y., Nagata Y., Nishimura Y., Abe M., Hasegawa M., Nagae H., Ebisawa Y. Targeted hyperthermia using dextran magnetite complex: a new treatment modality for liver tumors. Hepatogastroenterology 1996; 43(12): 1431-1437.
11. Yanase M, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T, Intracellular hyperthermia for cancer using magnetite cationic liposomes: ex vivo study. Jpn J Cancer Res Jul; 88 (7): 630-2.
12. Akagi K., Aoki Y., Nasu R., Nagata K., Itagaki Y., Sawada S. Enhancement of antitumor effects of hyperthermia with glucose administration in murine mammary carcinoma. Oncol Res 1999; 6(3): 593-596.
13. Lepper D. B., Engin K., Wang J. H., Cater J. R., Li D. J. Effect of i.v. versus combined i.v. plus oral glucose on human tumour extracellular pH for potential sensitization to thermoradiotherapy. Int J Hyperthermia 1998; 14(3): 257-269.
14. Lepper D. B., Engin K., Wang J. H., Cater J. R., Li D. J. Effect of i.v. versus combined i.v. plus oral glucose on human tumour extracellular pH for potential sensitization to thermoradiotherapy. Int J Hyperthermia 1998; 14(3): 257-269.
15. Payne A. G. The Revised Metabolic Oncolytic Regimen. Townsend Lett for Doctors & Patients 2001; 217/218: 78-85.
16. Lutsenko S. V., Feldman N. B., Finakova G. V., Posypanova G. A., Severin S. E., Skyrabin K. G., Kirpichnikov M. P., Lukyanets E. A., Vorozhtsov G. N. Targeting phthalocyanines to tumor cells using epidermal growth factor conjugates. Tumour Biol 1999; 20(4): 218-224.
17. Anbar M. Hyperthermia of the cancerous breast: analysis of mechanism. Cancer Lett 1994; 84(1): 23-29.
18. Lai, et al., Methods of inhibition or killing cancer cells using an endoperoxide, United States Patent #5;578:637 (November 26, 1996).
19. Lai, et al., Methods of inhibition or killing cancer cells using an endoperoxide, United States Patent #5;578:637 (November 26, 1996).
20. Lai, et al., Methods of inhibition or killing cancer cells using an endoperoxide, United States Patent #5;578:637 (November 26, 1996).
21. Lai, et al., Methods of inhibition or killing cancer cells using an endoperoxide, United States Patent #5;578:637 (November 26, 1996).
22. Lai, et al., Methods of inhibition or killing cancer cells using an endoperoxide, United States Patent #5;578:637 (November 26, 1996).
23. Lai, et al., Methods of inhibition or killing cancer cells using an endoperoxide, United States Patent #5;578:637 (November 26, 1996).
24. Ancient Chinese Folk Remedy May Hold Key to Non-Toxic Cancer Treatment (Science Daily article) http://www.sciencedaily.com/releases/2001/11/011127003905.htm.